Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-14 Sale |
2022-11-16 4:19 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
31,515 | $13.88 | $437,428 | 298,541 (Direct) |
View |
| 2022-03-07 Sale |
2022-03-09 4:24 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
20,000 | $17.16 | $343,200 | 230,056 (Direct) |
View |
| 2021-12-07 Sale |
2021-12-09 4:38 pm |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
30,100 | $12.2 | $367,220 | 215,056 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-14 Exercise |
2022-11-16 4:19 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
50,000 | $1.42 | 298,541 (Direct) |
View |
| 2022-11-14 Exercise |
2022-11-16 4:19 pm |
2014-01-01 2023-01-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
100,000 | $0 | 298,541 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 5:09 pm |
2022-12-14 2031-12-14 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
199,000 | $0 | 414,056 (Direct) |
View |
| 2021-12-07 Exercise |
2021-12-09 4:38 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
62,000 | $4.73 | 215,056 (Direct) |
View |
| 2021-12-07 Exercise |
2021-12-09 4:38 pm |
2013-03-01 2022-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Chief Discovery Officer |
62,000 | $0 | 215,056 (Direct) |
View |
| 2021-02-19 Tax Withholding |
2021-02-23 4:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
22,431 | $11.53 | 183,156 (Direct) |
View |
| 2021-02-19 Exercise |
2021-02-23 4:25 pm |
2012-03-01 2021-03-01 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
50,000 | $0 | 183,156 (Direct) |
View |
| 2021-02-19 Exercise |
2021-02-23 4:25 pm |
N/A N/A |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
50,000 | $4.15 | 183,156 (Direct) |
View |
| 2020-12-15 Option Award |
2020-12-17 4:30 pm |
2021-12-15 2030-12-15 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
280,000 | $0 | 280,000 (Direct) |
View |
| 2020-12-03 Option Award |
2020-12-07 4:19 pm |
2020-12-03 2023-08-08 |
BIOCRYST PHARMACEUTICALS INC | BCRX | Babu Yarlagadda S Senior VP - Drug Discovery |
17,000 | $0 | 17,000 (Direct) |
View |